Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Hepatitis B vaccine, recombinant

What type of immunity will be produced by the hepatitis B vaccine recombinant ... [Pg.582]

The same name is also being used for some vaccines that differ in potency. As shown in Table 1.4, the two approved vaccines against hepatitis B, Recombivax HB and Engerix-B, both known as Hepatitis B Vaccine (Recombinant), when used as directed, are therapeutically equivalent in terms of their ability to induce antibodies that protect vaccinated individuals from hepatitis B virus infection. However, the dose and volume required to produce a satisfactory immune response are different for each product and for each age group. [Pg.10]

Hepatitis B vaccine (recombinant), produced in yeast S. cerevisiae... [Pg.466]

Hepatitis B vaccine (Recombinant) recombinant hepatitis B surface antigen produced in S. cerevisiae (yeast). [Pg.493]

Hiere have been no major developments in recombinant vaccine production since the hepatitis B vaccine. Recombinant vaccines were produced against Lyme disease and rotavirus but have been subsequently withcbawn from the market. Recendy, an oral diolera vaccine (Dukoral) based on mixture on inactive cholera bacteria and a cholera toxin B subtmit produced by recombinant technology has been launched. [Pg.578]

Haemophilus influenzae type b conjugate and hepatitis B vaccine he -maw-fil-us in-flu-en -zah kon-jew -gate hep -ah-tie -tus bee-vak -seen Lyme disease vaccine (recombinant OspA) lime-vak -seen... [Pg.569]

The two hepatitis B vaccines available in the United States are Recombivax HB and Engerix-B. These vaccines are produced with recombinant DNA technology by inserting the gene for HBsAg into the plasmid that is synthesized by Saccharomyces cerevisiae cells. Both vaccines are effective in providing... [Pg.352]

Hepatitis B vaccine is manufactured using recombinant DNA technology to express hepatitis B surface antigen (HBsAg) in yeast. This is further purified with biochemical separation techniques to produce the vaccine. The vaccines are formulated to contain 10 to 40 meg of HBsAg protein/mL. Hepatitis B vaccine is available as a single component or in combination vaccines. [Pg.1243]

The yeast Hansenula polymorpha serves as the production system for a recombinant hepatitis B vaccine (Berna Biotech AG [8] and yeast is also used to produce granulocyte-macrophage colony stimulating factor (GM-CSF), marketed as Leukine by Schering AG. [Pg.268]

Glaser, R. et al., Stress-induced modulation of the immune response to recombinant hepatitis B vaccine, Psychosomat. Med., 54, 22, 1992. [Pg.521]

Recombinant hemoglobin, 4 124, 126 Recombinant hepatitis B vaccine, 25 502 Recombinant organisms... [Pg.791]

A), 3.8 billion Amgen s white blood cell stimulant, Neupogen (filgrastim), 3.0 billion interferon pia (Avonex for multiple sclerosis), 2.2 billion human growth hormone (HGH), 1.8 billion recombinant hepatitis B vaccine ( 1.0 billion) somatropin (Humatrope and Neutropin), 0.9 billion and cerezyme/ceredase (alglucerase), 0.6 billion. [Pg.620]

TABLE 1.4. Comparison of recombinant hepatitis B vaccines dose ... [Pg.10]

Hepatitis B Vaccine (Engerix-B, Recombivax HB) Human Papillomavirus (Types 6,11, 16,18) Recombinant Vaccine (Gardasil)... [Pg.50]

Hepatitis B Vaccine (Engerix-B, Recombivax HB) [Vaccine/ Inactivated] Uses Prevent Hep B Action Active immunization recombinant DNA Dose Adults. 3 EM doses 1 mL each 1st 2 doses 1 mo apart the 3rd 6 mo after the 1st Peds. 0.5 mL EM adult schedule Caution [C, +] 1 effect w/ immunosuppressives Contra Yeast allergy Disp Engerix-B Inj 20mcg/mL peds inj 10 mcg/0.5 mL Recombivax HB Inj 10 40 mcg/mL peds inj 5 mcg/0.5 mL SE Fever, inj site pain Interactions i Immune response W/ corticosteroids, immunosuppressants EMS None OD Unlikely... [Pg.183]

Merck licensed Chiron s recombinant hepatitis B vaccine. [Pg.213]

Recombinant techniques (Ogra et al. 2001) for generating purified antigens in large quantities have been used for the development of several vaccines including the hepatitis B virus vaccine (oral hepatitis B vaccine based on live recombinant adenovirus) (Lubeck et al. 1989). Other examples of recombinantly produced vaccines include vaccines containing tetanus toxoid, diphtheria toxin, and acellular pertussis toxoid. [Pg.201]

See other pages where Hepatitis B vaccine, recombinant is mentioned: [Pg.493]    [Pg.510]    [Pg.511]    [Pg.321]    [Pg.321]    [Pg.493]    [Pg.510]    [Pg.511]    [Pg.321]    [Pg.321]    [Pg.469]    [Pg.235]    [Pg.361]    [Pg.571]    [Pg.407]    [Pg.1249]    [Pg.210]    [Pg.861]    [Pg.183]    [Pg.441]    [Pg.31]    [Pg.122]    [Pg.469]    [Pg.213]    [Pg.1660]    [Pg.1354]    [Pg.302]    [Pg.218]    [Pg.306]   
See also in sourсe #XX -- [ Pg.321 ]

See also in sourсe #XX -- [ Pg.347 , Pg.350 ]



SEARCH



Hepatitis B Vaccination

Hepatitis B vaccine

Hepatitis vaccination

Hepatitis vaccine

Recombinant vaccines

© 2024 chempedia.info